3F8 monoclonal antibody treatment of patients with stage IV neuroblastoma: a phase II study

Prog Clin Biol Res. 1994:385:319-28.

Authors

N K Cheung¹, B H Kushner, S J Yeh, S M Larson

Affiliation

¹ Department of Pediatrics, Memorial Sloan-Kettering Cancer Center New York, NY 10021.

PMID: 7972227

No abstract available

Publication types

Clinical Trial
Clinical Trial, Phase II
Multicenter Study

MeSH terms

Antibodies, Monoclonal / therapeutic use*
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Child
Child, Preschool
Combined Modality Therapy
Female
Gangliosides / immunology*
Humans
Immunoglobulin G / immunology*
Infant
Infusions, Intravenous
Male
Neoplasm Staging
Neuroblastoma / pathology
Neuroblastoma / radiotherapy
Neuroblastoma / therapy*
Remission Induction
Retrospective Studies
Survival Analysis

Substances

Antibodies, Monoclonal
Gangliosides
Immunoglobulin G
ganglioside, GD2